MedTrace Logo

Comparative Effects of Post Facilitation Stretch and Active Release Technique in Female Patients With Piriformis Syndrome.

NCT07547059 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-23

No results posted yet for this study

Summary

This clinical study aimed to compare the effectiveness of Post-Facilitation Stretch (PFS) and Active Release Technique (ART) on pain, disability, quality of life, and range of motion of hip internal and external rotation in female patients with piriformis syndrome. After recruitment, participants were randomly allocated into two groups using the chit-box method, either in group A Post-Facilitation Stretch, and group B Active Release Technique. Clinical outcomes including pain, disability, quality of life, and hip range of motion (abduction and internal rotation) were assessed at baseline, during the third week of treatment, and at the sixth-week follow-up from the National Institute of Rehabilitation and Medicine (NIRM) Hospital.

Conditions

  • Piriformis Syndrome

Interventions

OTHER

Post Facilitation Stretch

Following a 10-minute application of a moist hot pack, participants were positioned supine with the hip flexed beyond 60° and gentle resistance was applied to facilitate an isometric external rotation contraction. This was followed by a passive stretch held for 15 seconds, performed for 5 repetitions per session.

OTHER

Active Release Technique

Following a 10-minute application of a moist hot pack, participants were positioned prone, and deep manual pressure was applied over the piriformis muscle for approximately 90 seconds while the patient actively moved the hip from internal to external rotation. This procedure was repeated for 10 repetitions per session.

Sponsors & Collaborators

  • Ibadat International University, Islamabad

    lead OTHER

Principal Investigators

  • Muhammad Nazim Farooq, PhD-PT · Ibadat International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-12-15
Completion
2025-12-15

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07547059 on ClinicalTrials.gov